LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset (ID:20259)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol 1 Concentration | Small Mol 1 Conc Unit | Small Molecule 2 | Small Mol 2 Concentration | Small Mol 2 Conc Unit | Biological Replicate | Technical Replicate | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 0 | uM | 2 | 1 | 1843 | 4947 | 5129 | 0.9516 | ||
| BT-20 | 0 | uM | 0 | uM | 1 | 3 | 2751 | 5189 | 4650 | 1.3112 | ||
| BT-20 | Dactolisib | 0.0137 | uM | 0 | uM | 3 | 2 | 280 | 553 | 588 | 0.8862 | |
| BT-20 | Alpelisib | 10 | uM | 0 | uM | 1 | 3 | 2751 | 781 | 4650 | -0.8103 | |
| BT-20 | 0 | uM | 0 | uM | 1 | 3 | 2751 | 5465 | 4650 | 1.4748 |